Embecta Corp. (FRA:JX7)

Germany · Delayed Price · Currency is EUR

9.75

-0.25 (-2.50%)

Last updated: Dec 5, 2025, 9:59 AM CET

-49.22% (1Y)

Market Cap	586.04M
Revenue (ttm)	920.82M
Net Income (ttm)	81.31M
Shares Out	n/a
EPS (ttm)	1.38
PE Ratio	7.21
Forward PE	3.96
Dividend	0.53 (5.47%)
Ex-Dividend Date	Dec 5, 2025

Volume	n/a
Average Volume	n/a
Open	9.75
Previous Close	10.00
Day's Range	9.75 - 9.75
52-Week Range	7.80 - 19.90
Beta	n/a
RSI	31.92
Earnings Date	Nov 25, 2025

About Embecta

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company’s products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient’s diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey. [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies

Founded 1924

Employees 1,850

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol JX7

Full Company Profile

Financial Performance

In 2025, Embecta's revenue was $1.08 billion, a decrease of -3.80% compared to the previous year's $1.12 billion. Earnings were $95.40 million, an increase of 21.84%.

Financial numbers in USD Financial Statements

News

There is no news available yet.